
Translational Pharmaceutics® Events
1 January 2025 - 31 March 2025Translational Pharmaceutics® Events
Ready to see how Translational Pharmaceutics® can be applied to your next drug program? Register today to attend an upcoming event with our Translational Pharmaceutics® experts.
Who benefits from using the Translational Pharmaceutics® platform?
The simple answer: many clients can benefit from the time and cost savings that Translational Pharmaceutics® brings to drug development.
We work with a range of clients, from large pharma to emerging startups, and have applied Translational Pharmaceutics® across indications and patient groups - in drugs that are targeted for use in oncology, rare diseases, and pediatrics, just to name a few. We see many cases where clients want to move rapidly into formulation optimization in a more efficient, controlled way. We also see clients with limited API availability or cases where API is costly to produce.
These are just a few examples but for more detailed case studies on how we apply Translational Pharmaceutics®, we also cover these in our seminars.
Learn about Translational Pharmaceutics® platform and its applications
Drug product optimization is a critical development step that is common for most drugs that are progressing through today’s development pipelines to respond to suboptimal exposure profiles, to transition from an early development drug formulation to one suitable for chronic administration in patients, or as part of a life-cycle management strategy. Learn more about this and other applications of Translational Pharmaceutics®.
Did you know that we can also apply the Translational Pharmaceutics® platform to your drug programs from our facilities in the UK as well as in the US? The expertise from our drug product facilities in Philadelphia, PA and clinical pharmacology facility in Miami, FL make this possible.
Stay in touch with us to find out about our next seminar series!
Have a question or want to stay in touch to learn about the Translational Pharmaceutics® platform? Join our mailing list.